10 research outputs found

    High fidelity equation of state for xenon

    No full text
    The noble gas xenon is a particularly interesting element. At standard pressure xenon is an fcc solid which melts at 161 K and then boils at 165 K, thus displaying a rather narrow liquid range on the phase diagram. On the other hand, under pressure the melting point is significantly higher: 3000 K at 30 GPa [1]. Under shock compression, electronic excitations become important at 40 GPa [2]. Finally, xenon forms stable molecules with fluorine (XeF2) suggesting that the electronic structure is significantly more complex than expected for a noble gas. With these reasons in mind, we studied the xenon Hugoniot using DFT/QMD [3] and validated the simulations with multi-Mbar shock compression experiments. The results show that existing equation of state models lack fidelity and so we developed a wide-range free-energy based equation of state using experimental data and results from first-principles simulations

    High fidelity equation of state for xenon

    No full text
    The noble gas xenon is a particularly interesting element. At standard pressure xenon is an fcc solid which melts at 161 K and then boils at 165 K, thus displaying a rather narrow liquid range on the phase diagram. On the other hand, under pressure the melting point is significantly higher: 3000 K at 30 GPa [1]. Under shock compression, electronic excitations become important at 40 GPa [2]. Finally, xenon forms stable molecules with fluorine (XeF2) suggesting that the electronic structure is significantly more complex than expected for a noble gas. With these reasons in mind, we studied the xenon Hugoniot using DFT/QMD [3] and validated the simulations with multi-Mbar shock compression experiments. The results show that existing equation of state models lack fidelity and so we developed a wide-range free-energy based equation of state using experimental data and results from first-principles simulations

    Management development: a literature review and implications for future research - Part II: Profiles and Contexts

    No full text
    In this second and concluding part of an extensive review of the management development literature, attention is directed to studies which have sought to describe and explain how managers are in fact made and to studies which have emphasised the contextual aspects of the process. The review is concluded with an overall assessment of the management development literature – its strengths and weaknesses – and with an analysis of the implications which this assessment carries for the conduct of future research. Crucial gaps are identified, not least of which is a general failure to locate descriptions of particular management development initiatives within the context of other ways in which the management stock is enhanced, replenished and managed. Another major shortcoming which is singled out as requiring urgent attention is the failure to place management development accounts and prescriptions within the wider context of organisational characteristics

    Tobacco Smoke Constituents Affecting Oxidative Stress

    No full text

    Carla Task Force on Sarcopenia: Propositions for clinical trials

    Full text link
    In the presence of an aging population, public health priorities need to evolve. As the populations gets older, the already existing pathologies have become commonplace with specific geriatric clinical syndromes like frailty, mobility disability, or cognitive impairment, among others. Sarcopenia is a good example for which geriatricians, neurologists, physiologists, nutritionists and epidemiologists need to find a consensual definition and diagnostic tool as well as guidelines for the management of clinical trials and possible treatments. The Carla Sarcopenia Task Force, which met in the south of France (Toulouse) for an expert consensus meeting called “Les Entretiens du Carla“, have addressed a series of existing issues to place Sarcopenia into a nosological context: a definition which should be a composite of a change in muscle mass and a change in strength/function depending on either a progressive and chronic wasting process or an acute onset of loss of muscle mass; a recommendation for DXA and the Short Physical Performance Battery as a clinical pragmatic approach of Sarcopenia; a differentiated approach for clinical studies according to prevention or treatment objectives and depending on the sub-groups and target populations; and finally, a summary of therapeutic strategies currently recommended. The aim of “Les Entretiens du Carla”, based on an expert meeting panel, was to address a series of unsolved issues in the field of Sarcopenia by combining the expert opinion with a revision of the existing literature on the topic. Through this report, the reader will appreciate the determination to find conclusions on the various issues and further studies to be developed to determine the best multidisciplinary approach needed

    Functional and neurobiological similarities of aging in monkeys and humans

    No full text
    corecore